DJIA 17,279.74 13.75 0.08%
NASDAQ 4,579.79 -13.64 -0.30%
S&P 500 2,010.40 -0.96 -0.05%
market minute promo

Integra LifeSciences (NASDAQ: IART)

49.76 -0.73 (-1.45%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

IART $49.76 -1.45%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $50.59
Previous Close $50.49
Daily Range $48.78 - $50.61
52-Week Range $38.47 - $51.32
Market Cap $1.6B
P/E Ratio -219.52
Dividend (Yield) $0.00 (0.0%)
Volume 359,746
Average Daily Volume 144,371
Current FY EPS $2.96

Sector

Healthcare

Industry

Healthcare Information Services

Integra LifeSciences (IART) Description

The Company is dedicated to improving the quality of life for patients through the development, manufacturing and marketing of cost-effective surgical implants and medical instruments. Website: http://www.integralife.com/

News & Commentary Rss Feed

Integra Beats on the Bottom Line

Resistance from payors over spine procedures pressures surgical technology specialist.

Update: Integra LifeSciences To Acquire Medtronic's Assets

Integra Poised on Impressive Duraseal Product Line, Solid Q2 - Analyst Blog

Integra LifeSciences Announces Changes Within Its Orthopedics And Tissue Technologies Business

InsiderInsights.com Daily Round Up 8/26/14: Aeropostale, AirT, SWK Holdings, Ironclad Performance We

InsiderInsights.com Daily Round Up 8/26/14: Aeropostale, AirT, SWK Holdings, Ironclad Performance Wear

Integra Lifesciences Holdings Corp Stock Upgraded (IART)

Integra LifeSciences Tops Q2 Earnings, Revenues, Shares Up - Analyst Blog

Integra LifeSciences Holdings' (IART) CEO Peter Arduini on Q2 2014 Results - Earnings Call Transcrip

Integra LifeSciences Holdings' (IART) CEO Peter Arduini on Q2 2014 Results - Earnings Call Transcript

Integra LifeSciences Holdings (IART) Q2 2014 Results - Earnings Call Webcast

Integra LifeSciences Announces Renewal And Extension Of Credit Facility; Increased From $600M to $90

Integra LifeSciences Announces Renewal And Extension Of Credit Facility; Increased From $600M to $900M

Integra Upbeat on DuraSeal Acquisition despite Tepid Q1 - Analyst Blog

See More IART News...

IART's Top Competitors

IART $49.76 (-1.45%)
Current stock: IART
COV $90.85 (-0.82%)
Current stock: COV
$0.00 (0.00%)
Current stock:
BAX $72.54 (-0.77%)
Current stock: BAX